Aveanna price target raised to $9.50 from $9 at Barclays
Barclays raised the firm's price target on Aveanna to $9.50 from $9 and keeps an Overweight rating on the shares. The firm adjusted targets among its U.S. healthcare facilities and managed care coverage ahead of Q2 earnings from the group.
50 from $9 and keeps an Overweight rating on the shares. S. healthcare facilities and managed care coverage ahead of Q2 earnings from the group.